Clinical Trials Browser

INDUSTRY × Myelodysplastic Syndromes × Receptors, Antigen, T-Cell × Clear all

NCT05358808 2025-09-30

ACHIEVE

Phase 2 Terminated

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06463327 2024-06-17

ACHIEVE2

Phase 1 Not yet recruiting

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute